Abbie G Freeman

Title: Abbie G Freeman: Innovator in Therapeutic Enzymes

Introduction

Abbie G Freeman is a notable inventor based in Columbia, SC (US). She has made significant contributions to the field of therapeutic enzymes, holding 2 patents that focus on innovative methods for producing glutaminase. Her work has implications for both antiviral and anticancer therapies.

Latest Patents

Freeman's latest patents include a method for producing therapeutically suitable glutaminase. This invention involves the molecular cloning of DNA encoding a glutaminase that is free of contaminating endotoxin. The resulting polypeptide has been identified as a potent anti-viral agent. When coupled with an anti-tumor monoclonal antibody, it serves as a powerful anticancer agent. This glutaminase is particularly effective in treating lung, breast, and colon cancer cells, as well as HIV-infected cells. Another patent focuses on genetically engineered glutaminase and its applications in antiviral and anticancer therapy, reinforcing her commitment to advancing medical science.

Career Highlights

Throughout her career, Freeman has worked with various organizations, including Me Medical Enzymes AG. Her expertise in the field has allowed her to develop groundbreaking solutions that address critical health challenges.

Collaborations

Freeman has collaborated with notable colleagues such as Joseph W Roberts and Thomas W MacAllister. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Abbie G Freeman's contributions to the field of therapeutic enzymes highlight her role as a pioneering inventor. Her patents not only advance scientific understanding but also offer potential solutions for serious health issues.